An interventional study of implant placement 6 months after ridge augmentation and implant placement Simultaneously with ridge augmentation in Alveolar Bone Loss and Dental Implant Failed, sponsored by Kafrelsheikh University. Active, not recruiting at 1 site in Egypt. Open to participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-25.
Sponsored by Kafrelsheikh University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 75 studies in Alveolar Bone Loss with a site in Egypt — 22 open to participants now, 27 under way, none of them phase 3. Alveolar Bone Loss · Egypt.
Among the 75 studies in Alveolar Bone Loss with a site in Egypt, this one is the 6th largest by enrollment of the 74 interventional ones that give a count, is one of 16 that started in 2024, is one of 68 with no phase, reaches primary completion later than 23 of the 26 other live ones, and was the 32nd registered.
320 studies on the registry are indexed under Alveolar Bone Loss; 79 are open to participants now.
Browse Alveolar Bone Loss studies →22 of the 75 studies in Alveolar Bone Loss with a site in Egypt are open now. Recruiting first, the newest first:
Horus University · Sites in Egypt
Ages 25–35 · Healthy volunteers
Beni-Suef University · Sites in Egypt
Ages 20–75 · Healthy volunteers
Al Salam University · Sites in Egypt
Ages 20–45 · Healthy volunteers
Future University in Egypt · Sites in Egypt
Ages 20–50
Basma Gamal Mohamed Ahmed · Sites in Egypt
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 47 Alveolar Bone Loss studies recruiting now, 19 (40%) set no upper age limit and 22 (47%) stop at 75 or younger; 4 take children under 18; 24 take healthy volunteers.
This study: 20 Years to 40 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
75 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 2 · Phase 3 1 · Phase 4 2
First in 2018; this study’s year is marked. 16 started in 2024.
This study's enrollment of 42 is above the median of 25 across 271 interventional studies indexed under Alveolar Bone Loss.
Median enrollment 20 across the 74 interventional studies, 23 across the 1 observational. Of the 37 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 75 has an industry lead sponsor. The 10 most frequent:
Kafrelsheikh University is the lead sponsor of 305 studies on the registry; 122 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Kafrelsheikh University has 4 studies filed under Alveolar Bone Loss — fewer than ten, so there is no comparison to draw.
6 of the studies in Alveolar Bone Loss with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07475507Cairo UniversityEffect of PEEK and Titanium Framework Reinforcement on Marginal Bone Loss Around Implants Supporting a Fixed All-on-four Prosthesis in Completely Edentulous Mandibles | 2026-12 |
| NCT07701473Cairo UniversityNovel Synthetic Membrane for Horizontal Bone Augmentation: A Case Series | 2027-03-01 |
| NCT06313229Kafrelsheikh UniversitySimultaneous Implant Placement With Vertical and Horizontal Bone Augmentation | 2027-04-30 |
| NCT07841158Mohammed Mahmoud AbedHistological and Histomorphometric Assessment With Inflammatory Profile Analysis of Bone Tissue After Horizontal Ridge Augmentation Using Customized Porous Zirconia Shell | 2027-05-01 |
| NCT07869030Future University in EgyptMelatonin Effect on Immediate Dental Implants in the Posterior Mandible | 2027-06 |
Add all 6 to your calendar (.ics) → With an account.
Among the 75 studies in Alveolar Bone Loss with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study was to report the clinical and radiographical outcomes of using autogenous cortical bone plates combined with sticky allogenic bone graft for augmenting maxillary anterior atrophic combined horizontal and vertical ridge defects with simultaneous versus staged implant placement.
Sufficient alveolar ridge is a prerequisite for successful implant stability, atrophic ridges defects make the placement of regular implants challenging. A variety of materials and surgical techniques are available for bone augmentation procedures prior implant placement. The present study evaluated the effect of sticky allogenic bone graft for the horizontal and vertical ridge augmentation with simultaneous implant placement using autogenous cortical bone plates in maxillary anterior atrophic ridge defects.
Forty-two patients, with severe maxillary anterior horizontal and vertical atrophic ridge deficiencies were randomly assigned to two groups: staged approach group and simultaneous implant placement group. The two groups were grafted using bone plated buccally and palatally and the defect between plates was grafted by sticky allogenic bone graft. Radiographic examination was performed immediately before bone grafting procedure and at 6, 12 months postoperatively, to evaluate the change of bone width and height.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
the bone defect was grafted using bone plates buccally and palatally and the defect between plates was grafted by sticky allogenic bone graft. 6 months later the implant was placed in the grafted site.
Procedure: implant placement 6 months after ridge augmentation
the bone defect was grafted using bone plates buccally and palatally and the defect between plates was grafted by sticky allogenic bone graft combined with simultaneous implant placement.
Procedure: implant placement Simultaneously with ridge augmentation
the deficient ridge was grafted first followed by implant placement after 6-monthes
the deficient ridge was grafted and followed by implant placement simultaneously
Stability Quotient of Implants (SQI)
The implant stability was recorded using Osstell TM. Following implant insertion, SQI readings were taken immediately, then again after six and twelve months.
Time frame: 36-month.
Horizontal bone dimensions (HBDs)
The HBD alterations were assessed by measuring horizontal spacing between the external edges of labial and palatal bony plates at a level 2mm apical of the fixture platform.
Time frame: 36-month.
Peri-implant Bone Density (PBD)
For consistent measurement of the PBD, 1-mm-diameter Region of interest (RI) was selected and traced 1.2 mm distant from the fixture on the cross-sectional slices followed by counting the threshold pixels inside the RI.
Time frame: 36-month.
Plan to share: Undecided — undecided
No publications or documents are linked to this record.
Started Apr 2024 (actual). Primary completion is estimated for Apr 2027, 36 months after the start.
Of 169 non-industry interventional studies with no phase under Alveolar Bone Loss, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's planned 36 months is above that.
Counting every sponsor, half of 169 studies reached it within 18 months; a quarter within 11 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.